Zobrazeno 1 - 7
of 7
pro vyhledávání: '"COS Savage"'
Publikováno v:
Revista Cubana de Medicina, Vol 37, Iss 2, Pp 100-111 (1998)
Externí odkaz:
https://doaj.org/article/b400a45c1654418a8aa555637efcca2b
Publikováno v:
Transplant Immunology. 5:39-44
A major barrier to the transplantation of a porcine organ into a human recipient is the hyperacute rejection response which has been shown to be mediated by xenoreactive antibodies (XAb) and complement proteins. Here, evidence is presented that norma
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4fc64499d55cee840375e790805cbc67
https://doi.org/10.1016/s0966-3274(97)80024-x
https://doi.org/10.1016/s0966-3274(97)80024-x
Autor:
Cos Savage, J Lepenies, M Hewison, Paul M. Stewart, Marcus Quinkler, Stephen A. Hughes, Daniel Zehnder
Publikováno v:
Experimental and Clinical Endocrinology & Diabetes. 112
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::10fb1636287806437a8d3e73b9656c98
https://doi.org/10.1055/s-2004-819182
https://doi.org/10.1055/s-2004-819182
Publikováno v:
Clinical Science. 82:1P-1P
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::cb67dbf143683558371a27ed4f56843d
https://doi.org/10.1042/cs082001pa
https://doi.org/10.1042/cs082001pa
Autor:
Ellis J; GlaxoSmithKline, Stevenage, Hertfordshire, UK., J B Marks D; GlaxoSmithKline, Stevenage, Hertfordshire, UK., Srinivasan N; GlaxoSmithKline, Stevenage, Hertfordshire, UK., Barrett C; GlaxoSmithKline, Stevenage, Hertfordshire, UK., Hopkins TG; GlaxoSmithKline, Stevenage, Hertfordshire, UK., Richards A; GlaxoSmithKline, Stevenage, Hertfordshire, UK., Fuhr R; Parexel International, Berlin, Germany., Albayaty M; Parexel International, London, UK., Coenen M; Study Center Bonn (SZB), Institute of Clinical Chemistry and Clinical Pharmacology, University Hospital Bonn, Bonn, Germany., Liefaard L; GlaxoSmithKline, Stevenage, Hertfordshire, UK., Leavens K; GlaxoSmithKline, Stevenage, Hertfordshire, UK., Nevin KL; GlaxoSmithKline, Stevenage, Hertfordshire, UK., Tang S; GlaxoSmithKline, Upper Providence, Pennsylvania, USA., Hughes SA; GlaxoSmithKline, Stevenage, Hertfordshire, UK., Fortunato L; GlaxoSmithKline, Stevenage, Hertfordshire, UK., Edwards K; GlaxoSmithKline, Stevenage, Hertfordshire, UK., Cui Y; GlaxoSmithKline, Stevenage, Hertfordshire, UK., Anselm R; GlaxoSmithKline, Stevenage, Hertfordshire, UK., Delves CJ; GlaxoSmithKline, Stevenage, Hertfordshire, UK., Charles E; GlaxoSmithKline, Stevenage, Hertfordshire, UK., Feeney M; GlaxoSmithKline, Stevenage, Hertfordshire, UK., Webb TM; GlaxoSmithKline, Stevenage, Hertfordshire, UK., Brett SJ; GlaxoSmithKline, Stevenage, Hertfordshire, UK., Schmidt TS; GlaxoSmithKline, Stevenage, Hertfordshire, UK., Stone J; GlaxoSmithKline, Stevenage, Hertfordshire, UK., Savage COS; GlaxoSmithKline, Stevenage, Hertfordshire, UK., Wisniacki N; GlaxoSmithKline, Stevenage, Hertfordshire, UK., Tarzi RM; GlaxoSmithKline, Stevenage, Hertfordshire, UK.
Publikováno v:
Clinical pharmacology and therapeutics [Clin Pharmacol Ther] 2021 May; Vol. 109 (5), pp. 1293-1303. Date of Electronic Publication: 2020 Nov 24.
Autor:
Kitching AR; Centre for Inflammatory Diseases, Monash University Department of Medicine, Monash Medical Centre, Clayton, Victoria, Australia. richard.kitching@monash.edu.; Departments of Nephrology and Paediatric Nephrology, Monash Health, Clayton, Victoria, Australia. richard.kitching@monash.edu., Anders HJ; Renal Division, Medizinische Klinik und Poliklinik IV, LMU Klinikum, Ludwig-Maximilians University, Munich, Germany., Basu N; Institute of Infection, Immunity and Inflammation, University of Glasgow, Glasgow, UK., Brouwer E; Vasculitis Expertise Centre Groningen, Department of Rheumatology and Clinical Immunology, University of Groningen, University Medical Centre Groningen, Groningen, Netherlands., Gordon J; Department of Neuroscience and Center for Neurovirology, Temple University School of Medicine, Philadelphia, PA, USA., Jayne DR; Department of Medicine, University of Cambridge School of Clinical Medicine, University of Cambridge, Cambridge Biomedical Campus, Cambridge, UK., Kullman J; Vasculitis Foundation, Kansas City, MO, USA., Lyons PA; Department of Medicine, University of Cambridge School of Clinical Medicine, University of Cambridge, Cambridge Biomedical Campus, Cambridge, UK.; Cambridge Institute for Therapeutic Immunology and Infectious Disease, Jeffrey Cheah Biomedical Centre, University of Cambridge, Cambridge, UK., Merkel PA; Division of Rheumatology, Department of Medicine and Division of Clinical Epidemiology, Department of Biostatistics, Epidemiology, and Informatics, University of Pennsylvania, Philadelphia, PA, USA., Savage COS; Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, UK., Specks U; Division of Pulmonary and Critical Care Medicine, Mayo Clinic College of Medicine and Science, Rochester, MN, USA., Kain R; Department of Pathology, Medical University Vienna, Vienna, Austria.
Publikováno v:
Nature reviews. Disease primers [Nat Rev Dis Primers] 2020 Aug 27; Vol. 6 (1), pp. 71. Date of Electronic Publication: 2020 Aug 27.
Autor:
Yang JHM; Department of Immunobiology, School of Immunology & Microbial Sciences (SIMS), King's College London, London, United Kingdom.; NIHR Biomedical Research Centre, Guy's and St Thomas' NHS Foundation Trust and King's College London, London, United Kingdom., Khatri L; Department of Immunobiology, School of Immunology & Microbial Sciences (SIMS), King's College London, London, United Kingdom.; NIHR Biomedical Research Centre, Guy's and St Thomas' NHS Foundation Trust and King's College London, London, United Kingdom., Mickunas M; Department of Immunobiology, School of Immunology & Microbial Sciences (SIMS), King's College London, London, United Kingdom.; NIHR Biomedical Research Centre, Guy's and St Thomas' NHS Foundation Trust and King's College London, London, United Kingdom., Williams E; Department of Immunobiology, School of Immunology & Microbial Sciences (SIMS), King's College London, London, United Kingdom.; NIHR Biomedical Research Centre, Guy's and St Thomas' NHS Foundation Trust and King's College London, London, United Kingdom., Tatovic D; Diabetes/Autoimmunity Research Group, Cardiff University School of Medicine, Cardiff, United Kingdom., Alhadj Ali M; Diabetes/Autoimmunity Research Group, Cardiff University School of Medicine, Cardiff, United Kingdom., Young P; Public Health Wales, Cardiff, United Kingdom., Moyle P; Experimental Medicine and Immunotherapeutics (EMIT), Department of Medicine, University of Cambridge, Cambridge, United Kingdom., Sahni V; GlaxoSmithKline Medicines Research Centre, Stevenage, United Kingdom., Wang R; GlaxoSmithKline Medicines Research Centre, Stevenage, United Kingdom., Kaur R; GlaxoSmithKline Medicines Research Centre, Stevenage, United Kingdom., Tannahill GM; GlaxoSmithKline Medicines Research Centre, Stevenage, United Kingdom., Beaton AR; GlaxoSmithKline Medicines Research Centre, Stevenage, United Kingdom., Gerlag DM; GlaxoSmithKline Medicines Research Centre, Stevenage, United Kingdom., Savage COS; GlaxoSmithKline Medicines Research Centre, Stevenage, United Kingdom., Napolitano Rosen A; GlaxoSmithKline Medicines Research Centre, Stevenage, United Kingdom., Waldron-Lynch F; Experimental Medicine and Immunotherapeutics (EMIT), Department of Medicine, University of Cambridge, Cambridge, United Kingdom., Dayan CM; Diabetes/Autoimmunity Research Group, Cardiff University School of Medicine, Cardiff, United Kingdom., Tree TIM; Department of Immunobiology, School of Immunology & Microbial Sciences (SIMS), King's College London, London, United Kingdom.; NIHR Biomedical Research Centre, Guy's and St Thomas' NHS Foundation Trust and King's College London, London, United Kingdom.
Publikováno v:
Frontiers in immunology [Front Immunol] 2019 Oct 31; Vol. 10, pp. 2547. Date of Electronic Publication: 2019 Oct 31 (Print Publication: 2019).